Considerations on the use of urine markers in the management of patients with high-grade non-muscle-invasive bladder cancer.
暂无分享，去创建一个
A. Vlahou | B. Schmitz-Dräger | A. Kamat | B. V. van Rhijn | T. Todenhöfer | W. Kassouf | M. Ingersoll | H. Barton Grossman | John A. Taylor | P. Goebell | B. Pesch | A. Chandra | T. Behrens | J. Palou | M. Hudson | M. Sánchez-Carbayo